These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12473583)

  • 41. Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer.
    Macher-Goeppinger S; Aulmann S; Tagscherer KE; Wagener N; Haferkamp A; Penzel R; Brauckhoff A; Hohenfellner M; Sykora J; Walczak H; Teh BT; Autschbach F; Herpel E; Schirmacher P; Roth W
    Clin Cancer Res; 2009 Jan; 15(2):650-9. PubMed ID: 19147771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. WHO grade related expression of TRAIL-receptors and apoptosis regulators in meningioma.
    Koschny R; Krupp W; Xu LX; Mueller WC; Bauer M; Sinn P; Keller M; Koschny T; Walczak H; Bruckner T; Ganten TM; Holland H
    Pathol Res Pract; 2015 Feb; 211(2):109-16. PubMed ID: 25481563
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of tumor necrosis factor-related apoptosis-inducing ligand on developing human oligodendrocytes in culture].
    Xiao ML; Liu JQ; Chen C
    Mol Biol (Mosk); 2014; 48(6):963-9. PubMed ID: 25845236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of preventive and therapeutic activity of novel non-steroidal anti-inflammatory drug, CG100649, in colon cancer: Increased expression of TNF-related apoptosis-inducing ligand receptors enhance the apoptotic response to combination treatment with TRAIL.
    Woo JK; Kang JH; Jang YS; Ro S; Cho JM; Kim HM; Lee SJ; Oh SH
    Oncol Rep; 2015 Apr; 33(4):1947-55. PubMed ID: 25672292
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comprehensive expression analysis of TNF-related apoptosis-inducing ligand and its receptors in colorectal cancer: Correlation with MAPK alterations and clinicopathological associations.
    Tsikalakis S; Chatziandreou I; Michalopoulos NV; Theodoropoulos GE; Sakellariou S; Korkolopoulou P; Patsouris E; Saetta AA
    Pathol Res Pract; 2018 Jun; 214(6):826-834. PubMed ID: 29731264
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression.
    Eggert A; Grotzer MA; Zuzak TJ; Wiewrodt BR; Ho R; Ikegaki N; Brodeur GM
    Cancer Res; 2001 Feb; 61(4):1314-9. PubMed ID: 11245427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic significance of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in patients with breast cancer.
    Ganten TM; Sykora J; Koschny R; Batke E; Aulmann S; Mansmann U; Stremmel W; Sinn HP; Walczak H
    J Mol Med (Berl); 2009 Oct; 87(10):995-1007. PubMed ID: 19680616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The TRAIL-receptor-1: TRAIL-receptor-3 and -4 ratio is a predictor for TRAIL sensitivity of cancer cells.
    Büneker C; Mohr A; Zwacka RM
    Oncol Rep; 2009 May; 21(5):1289-95. PubMed ID: 19360306
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2005 May; 34(5):287-94. PubMed ID: 15817072
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ultraviolet light downregulates CD95 ligand and TRAIL receptor expression facilitating actinic keratosis and squamous cell carcinoma formation.
    Bachmann F; Buechner SA; Wernli M; Strebel S; Erb P
    J Invest Dermatol; 2001 Jul; 117(1):59-66. PubMed ID: 11442750
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overexpression of FLIPL is an independent marker of poor prognosis in colorectal cancer patients.
    Ullenhag GJ; Mukherjee A; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
    Clin Cancer Res; 2007 Sep; 13(17):5070-5. PubMed ID: 17785559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis.
    Kim JH; Ajaz M; Lokshin A; Lee YJ
    Clin Cancer Res; 2003 Aug; 9(8):3134-41. PubMed ID: 12912965
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A study of TRAIL receptors in squamous cell carcinoma of the head and neck.
    Teng MS; Brandwein-Gensler MS; Teixeira MS; Martignetti JA; Duffey DC
    Arch Otolaryngol Head Neck Surg; 2005 May; 131(5):407-12. PubMed ID: 15897419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Involvement of TRAIL/TRAIL-receptors in human intestinal cell differentiation.
    Rimondi E; Secchiero P; Quaroni A; Zerbinati C; Capitani S; Zauli G
    J Cell Physiol; 2006 Mar; 206(3):647-54. PubMed ID: 16245299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha.
    Sheikh MS; Burns TF; Huang Y; Wu GS; Amundson S; Brooks KS; Fornace AJ; el-Deiry WS
    Cancer Res; 1998 Apr; 58(8):1593-8. PubMed ID: 9563466
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family.
    Degli-Esposti MA; Smolak PJ; Walczak H; Waugh J; Huang CP; DuBose RF; Goodwin RG; Smith CA
    J Exp Med; 1997 Oct; 186(7):1165-70. PubMed ID: 9314565
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alternative functions for TRAIL receptors in eosinophils and neutrophils.
    Daigle I; Simon HU
    Swiss Med Wkly; 2001 May; 131(17-18):231-7. PubMed ID: 11420819
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
    Yamamoto T; Nagano H; Sakon M; Wada H; Eguchi H; Kondo M; Damdinsuren B; Ota H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Yagita H; Monden M
    Clin Cancer Res; 2004 Dec; 10(23):7884-95. PubMed ID: 15585621
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcriptional regulation of the TRAIL-R3 gene.
    Ruiz de Almodóvar C; López-Rivas A; Redondo JM; Rodríguez A
    Vitam Horm; 2004; 67():51-63. PubMed ID: 15110171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.